Understanding Essential Hypertension and the Role of Amlodipine: Pathophysiology and Pharmacological Management PHA4032

Introduction and Normal Physiology

Essential hypertension (HTN) also known as primary hypertension is a medical condition characterized by consistently elevated blood pressure and where both systolic and diastolic blood blood pressure are significantly increased (Iqbal & Jamal 2023). In context with pathophysiology, there are two types of hypertension such as essential hypertension and secondary hypertension. Primary hypertension accounts for 85% to 95% of occurrences in humans. Specific underlying diseases, such as renal artery stenosis, pheochromocytoma, adrenal adenoma, or single gene mutations are the primary causes of this type of hypertension (Ma & Chen 2022). Based on the review from Dilmurodovna (2024), different types of inflammatory processes also help to influence the prevalence of essential hypertension, as a binder, chronic subclinical vascular inflammation is directly linked with essential hypertension.

The ability of living organisms to maintain a constant internal environment in the face of changing external circumstances is known as homeostasis (Billman 2020). To maintain this balance, it is essential to keep the conditions of the body within specific bounds. This particular aspect is also essential for the healthy operation of cells, tissues, and organs. Homeostasis controls vital characteristics such as pH, temperature, glucose levels, water balance, and electrolyte concentrations (Beckett et al. 2023). During the time of essential hypertension, the mechanism of homeostasis such as both positive and negative feedback has been significantly disrupted leading to increased blood pressure (Madhur et al. 2021).

Calcium-channel blocker (CCBs) is a kind of therapeutic agent that may reduce blood pressure and block calcium entry into the heart, as well as within arteries. The major type of mechanisms for CCBs is also the vasodilator with this mechanism, it helps to ease off the blood vessels and keep up circulation (Savage et al. 2020). Some CCBs act by causing heart rate slowing, for example the non-dihydropyridine types. Reducing the heart rate can benefit high blood pressure by reducing stress on the heart.

The present essay has been written with the aim of confining to review excerpts on essential hypertension and role in treatment by calcium channel blockers. In other study, Amlodipine is a particular CCB chosen.

Pathophysiology

The multifactorial nature of hypertension pathogenesis is a consequence of the interplay between genetic, environmental and lifestyle factors leading to chronically high blood pressure. This perhaps is consequence of endothelial dysfunction whereby inner lining are unable to control the vascular tone in blood vessel efficiently (Nwabuo & Vasan 2020). An additional factor is the over activation of renin-angiotensin system, which result in vasoconstriction and increase blood volume. The RAAS, in turn regulates blood pressure and fluid balance.

Pathophysiology of hypertension is multifactorial involving intricate play of genetic, environmental and lifestyle factors contributing to having high blood pressure consistently (Steckelings and Unger, 2019). Elevated peripheral vascular resistance, often secondary to stiffening/narrowing of the blood vessel walls (Harrison et al., 2021). This is because of endothelial dysfunction, where the lining inside does not properly govern the vascular tone within blood vessels (Nwabuo & Vasan 2020). In addition, inappropriate stimulation of the renin-angiotensin-aldosterone system (RAAS) presumed to contribute for vasoconstriction and risk of hypertention.

When related to the pathophysiology of vascular-remodelling, it is possible to state that artery wall thickening and increased stiffness are the factors which contribute to elevated peripheral resistance. The pathophysiology of hypertension also includes endothelial dysfunction including reduced synthesis of Nitric oxide and increased oxidation products. RAAS, SNS hyperactivity, salt retention, vascular remodelling, endothelial dysfunction and hormonal changes are the main mechanisms of its action. There is need to understand these pathways in order to design interventions to prevent, manage, or treat hypertension.

Pharmacology

There are two categories of hypertension control that include medicinal and non-medicinal. In all patients with hypertension, non-pharmacologic and lifestyle therapy are the principal components of antihypertensive therapy irrespective of the patients age, gender, presence of comorbidity and CVD risk (Shahzad et al. 2023). It has also been proved that it is possible to organize the work of an out-patient department more efficiently if the patients themselves are informed as far as possible. Drug treatment is managed with respect to age, race, and other co morbid conditions including renal disease, left ventricular dysfunction, congestive heart failure and stroke. These are ACE inhibitors, ARBs, diuretics especially thiazides, CCBs and BBs (Al-Makki et al. 2021). Regarding therapeutic aspects, Calcium-channel blockers (CCBs) have been selected for this particular study and amongst them Amlodipine.
Specific drug: Amlodipine
Brand Name: Norvasc
Generic name: Norvasc
Chemical name: dialkyl 1, 4-dihydropyridine-3, 5-dicarboxylate derivative

After oral use, Amlodipine is well absorbed from the digestive system, having a bioavailability of roughly 6065%. 6-12 hours after intake, it achieves its highest plasma concentrations (Chen et al. 2022). Moreover, CYP3A4, a cytochrome P450 enzyme, is involved in the extensive hepatic metabolism of amlodipine. In context with elimination, it can also be argued that, Amlodipine has a rather lengthy elimination half-life, lasting between 30 and 50 hours. Due to its extended half-life, the medication can be taken once daily, improving patient compliance and ensuring steady blood pressure control (Wang et al. 2020).

Amlodipine is a common dihydropyridine calcium channel blocker (CCB) used to treat angina and hypertension. Its pharmacodynamic effects include lowering blood pressure and causing vasodilation via modifying the inflow of calcium ions into cardiac muscle cells and vascular smooth muscle (Ibrahim Abdelsalam Abdelrahman et al. 2023). The pharmacodynamic effects of amlodipine include the selective suppression of calcium entry into vascular smooth muscle cells, which lowers blood pressure and causes vasodilation. It is a useful and well-tolerated treatment option for angina and hypertension because to its strong vascular selectivity, prolonged duration of action, and low cardiac side effects. Moreover, oral administration of amlodipine is the most popular and practical clinical method for patients (AL-Japairai & Mahmood 2021).

The patient should aware of the side effects and drug interactions. Though generally and medically well accepted, amlodipine may interact with several drugs and herbal remedies, changing its effects or raising the possibility of adverse effects. For patients to properly manage their health, it is critical to understand these relationships. Itraconazole, ritonavir are the drug thatblock the CYP3A4 enzyme, which is necessary for amlodipine metabolism (Balasubramanian & Maideen 2021). Amlodipine plasma concentrations may raise as a result of co-administration, raising the possibility of adverse-affects such edema,vertigo. Regular monitoring and consult with the healthcare professional cam reduce this adverse effect.

Clinical Relevance

Some of the members that have been investigated and used include; amlodipine which has been discussed in treating hypertension. Blood pressure can be controlled with the help of Amlodipine which is a calcium channel blocker agent. Therefore solicitude of the treatment and prevention for use that is certain, direct pharmacological actions and safety of the certain study are significant.

Amlodipine belongs to the group of dihydropyridine and it is classified as calcium channel blockers. Among its main plies of action, it is to prevent calcium ions through the L type calcium channel in smooth muscles of the blood vessels. This sequence demonstrated that calcium ions are required for muscles contraction especially the vascular smooth muscle (Wang et al. 2023). It does this through the following mechanisms; it depresses these channels through which it lowers intracellular calcium thus leading to relaxation of the vascular smooth muscle. From this relaxation, dilatation predominantly of arteries occurs with subsequent decrease in blood pressure and peripheral vascular resistance.

Amlodipine is an antihypertensive medication because of its ability to selectively inhibit the L-type calcium channels in vascular smooth muscles than in the cardiac muscles thus reducing its effect on the rate and contractility of the heart in comparison to non dihydropyridine calcium channel blockers such as verapamil and diltiazem. Amlodipine has a very long half-life of approximately 30-50 hours and therefore it can be prescribed at a single dose daily making patient compliancy high (Sinha & Agarwal, 2018).

According to this qualitative study, it was identified that amlodipine is effective in managing BP and negated cardiovascular event (Kumar et al. 2021). Thus, the effect of amlodipine was compared with other classes of anti-hypertensive agents such as lisinopril, an ACE inhibitor and chlorthalidone, a diuretic in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) (Wang et al. 2022). In Amids, it was clear that engaging amlodipine in the trial has demonstrated the drug to be a suitable first line antihypertensive that could prevent major cardiovascular events as much as other medications did.

First of all, amlodipine is safe and the drug is usually, unless contraindicated, well tolerated without severe side effects. They also experience some light side effects which include; some of the side effects are as a result of the dosages of the drug given. Compared with other calcium channel blockers, amlodipine appear to have fewer dangerous side effects, which are potentially fatal or potentially fatal hypotension as well as bradycardia or heart blockage (Siddiqi & Shatat 2019).

Thus, one of the advantages that include the class but were not seen with some other forms of antihypertensive agents is a lack of new-onset diabetes with long-term amlodipine treatment. Regarding the lipid profile amlodipine is either inert or may be even beneficial since dyslipidemia is a common co morbidity.

Being one of the calcium channel blocker, amlodipine is critically involved in the management of hypertension. It works by reducing blood pressure to the barest level and preventing instances of cardiovascular related incidents through inhibitory effects to calcium ion and promotion of blood vessels dilation. It is relevant to underline that amlodipine is rather diverse and helpful approach for the treatment of hypertension as it is applicable for patients with numerous complicating factors. Since amlodipine is a relatively safe drug, it facilitates a decreased disease load in terms of cardiovascular issues and better outcomes for the patients. Even today, hypertension is considered as one of the leading global health issues.

Are you struggling to keep up with the demands of your academic journey? Don't worry, we've got your back!
Exam Question Bank is your trusted partner in achieving academic excellence for all kind of technical and non-technical subjects. Our comprehensive range of academic services is designed to cater to students at every level. Whether you're a high school student, a college undergraduate, or pursuing advanced studies, we have the expertise and resources to support you.

To connect with expert and ask your query click here Exam Question Bank